What are your thoughts on RELYVRIO previously known as AMX0035? Could it benefit PD patients as well?
RELYVRIO (previously known as AMX0035 in the U.S.) is an oral, fixed-dose combination therapy for the treatment of adults with ALS
RELYVRIO significantly slowed the loss of physical function in a randomized, placebo-controlled clinical trial in ALS
https://www.alzforum.org/therapeutics/relyvrio
RELYVRIO (previously known as AMX0035 in the U.S.) is an oral, fixed-dose combination therapy for the treatment of adults with ALS
RELYVRIO significantly slowed the loss of physical function in a randomized, placebo-controlled clinical trial in ALS
https://www.alzforum.org/therapeutics/relyvrio